Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Trovagene Names Elander as CSO; Curetis Hires Hilbert to Head Biz Development

Premium

Trovagene said this week that it has appointed Mark Elander as chief scientific officer. Erlander will direct the clinical development program for the company's portfolio of transrenal and urine-based molecular diagnostic assays. He will also oversee the ongoing clinical program for Trovagene's human papilloma virus carrier screening assay.

Elander previously served as CSO of BioTheranostics, a BioMérieux company. Prior to this, he was a research fellow at the RW Johnson Pharmaceutical Research Institute, part of Johnson & Johnson. He has also been a postdoctoral fellow in the Department of Molecular Biology at Scripps Research Institute. He holds a BS in biochemistry from the University of California, Davis; an MS in biochemistry from Iowa State University, and a PhD in neuroscience from the University of California, Los Angeles.


Curetis this week said that it has appointed Helmut Hilbert as head of business development.

Hilbert was previously employed by Qiagen, where he served in a number of scientific and business development positions, most recently associate director of corporate business development. He holds a PhD in molecular biology from the Open University/University of Heidelberg.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.